TADALAFIL

TADALAFIL was reported 101027 times

These side effects are most commonly reported by patients taking TADALAFIL:

# Side effect Count
0 DYSPNOEA 12170
1 HEADACHE 11213
2 DIARRHOEA 8190
3 NAUSEA 6829
4 FATIGUE 6241
5 DEATH 6069
6 DRUG INEFFECTIVE 5626
7 DIZZINESS 5452
8 COUGH 4578
9 PNEUMONIA 4359
10 MALAISE 3852
11 VOMITING 3587
12 PAIN 3448
13 ASTHENIA 3432
14 PAIN IN EXTREMITY 3424
15 FLUID RETENTION 3225
16 OFF LABEL USE 3210
17 HYPOTENSION 3122
18 PULMONARY ARTERIAL HYPERTENSION 2897
19 FLUSHING 2865
20 CHEST PAIN 2762
21 BACK PAIN 2701
22 DYSPNOEA EXERTIONAL 2477
23 PAIN IN JAW 2462
24 ARTHRALGIA 2361
25 NASAL CONGESTION 2329
26 WEIGHT DECREASED 2326
27 FALL 2321
28 PERIPHERAL SWELLING 2269
29 OEDEMA PERIPHERAL 2267
30 OXYGEN SATURATION DECREASED 2239
31 MYALGIA 2186
32 SYNCOPE 2178
33 NASOPHARYNGITIS 2081
34 CONDITION AGGRAVATED 2068
35 FEELING ABNORMAL 2068
36 PYREXIA 2015
37 DECREASED APPETITE 1856
38 INFUSION SITE PAIN 1829
39 PULMONARY HYPERTENSION 1773
40 PALPITATIONS 1731
41 HYPERTENSION 1703
42 ANAEMIA 1695
43 OEDEMA 1685
44 WEIGHT INCREASED 1664
45 INSOMNIA 1614
46 HOSPITALISATION 1603
47 CARDIAC FAILURE 1562
48 ABDOMINAL DISCOMFORT 1520
49 ABDOMINAL PAIN UPPER 1498
50 RASH 1481
51 EPISTAXIS 1452
52 ANXIETY 1444
53 CHEST DISCOMFORT 1435
54 VISION BLURRED 1374
55 MUSCLE SPASMS 1359
56 ATRIAL FIBRILLATION 1270
57 ABDOMINAL PAIN 1237
58 PRODUCT DOSE OMISSION ISSUE 1225
59 LOSS OF CONSCIOUSNESS 1206
60 CONSTIPATION 1197
61 HEART RATE INCREASED 1175
62 DYSPEPSIA 1170
63 PRURITUS 1148
64 DEPRESSION 1140
65 ABDOMINAL DISTENSION 1121
66 CARDIAC FAILURE CONGESTIVE 1109
67 RIGHT VENTRICULAR FAILURE 1108
68 CARDIAC DISORDER 1105
69 DRUG DOSE OMISSION 1096
70 UNEVALUABLE EVENT 1080
71 INFUSION SITE ERYTHEMA 1073
72 INFLUENZA 1041
73 URINARY TRACT INFECTION 1032
74 BLOOD PRESSURE DECREASED 1027
75 SWELLING 1027
76 RENAL FAILURE 1017
77 DEHYDRATION 1003
78 GASTROOESOPHAGEAL REFLUX DISEASE 981
79 HYPOXIA 974
80 COVID-19 965
81 HOT FLUSH 950
82 FLUID OVERLOAD 935
83 VISUAL IMPAIRMENT 934
84 SOMNOLENCE 924
85 ERYTHEMA 922
86 DEVICE RELATED INFECTION 907
87 PULMONARY OEDEMA 895
88 RESPIRATORY FAILURE 892
89 OROPHARYNGEAL PAIN 883
90 ERECTILE DYSFUNCTION 875
91 BLOOD CHOLESTEROL INCREASED 873
92 GAIT DISTURBANCE 867
93 SINUSITIS 864
94 PRODUCTIVE COUGH 854
95 THERAPEUTIC RESPONSE DECREASED 851
96 SEPSIS 836
97 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 825
98 HAEMOGLOBIN DECREASED 821
99 MIGRAINE 819
100 PRODUCT USE ISSUE 819
101 INFECTION 815
102 CHILLS 809
103 THERAPY NON-RESPONDER 808
104 BRONCHITIS 781
105 ACUTE KIDNEY INJURY 777
106 DERMATITIS CONTACT 767
107 MALIGNANT MELANOMA 759
108 THROAT IRRITATION 749
109 DISEASE PROGRESSION 720
110 PLEURAL EFFUSION 720
111 JOINT SWELLING 718
112 GASTROINTESTINAL HAEMORRHAGE 713
113 BLOOD TESTOSTERONE DECREASED 708
114 RHINORRHOEA 706
115 MYOCARDIAL INFARCTION 703
116 BLOOD PRESSURE INCREASED 693
117 DEVICE DISLOCATION 692
118 DIABETES MELLITUS 688
119 HYPERSENSITIVITY 684
120 BENIGN PROSTATIC HYPERPLASIA 673
121 CEREBROVASCULAR ACCIDENT 671
122 THERAPY INTERRUPTED 670
123 GASTROINTESTINAL DISORDER 654
124 INCORRECT DOSE ADMINISTERED 648
125 DRUG INTERACTION 638
126 CONFUSIONAL STATE 633
127 SEASONAL ALLERGY 631
128 INFUSION SITE SWELLING 624
129 ILLNESS 622
130 INJECTION SITE PAIN 617
131 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 612
132 DRUG INTOLERANCE 608
133 HAEMORRHAGE 605
134 HYPOAESTHESIA 604
135 SLEEP DISORDER 599
136 PARAESTHESIA 597
137 MEMORY IMPAIRMENT 593
138 INTENTIONAL PRODUCT MISUSE 592
139 PERICARDIAL EFFUSION 591
140 CHRONIC KIDNEY DISEASE 590
141 DEVICE ISSUE 586
142 TREMOR 583
143 PLATELET COUNT DECREASED 578
144 DRUG HYPERSENSITIVITY 573
145 LUNG DISORDER 572
146 HAEMOPTYSIS 569
147 WHEEZING 560
148 MUSCULAR WEAKNESS 558
149 HYPERHIDROSIS 557
150 TACHYCARDIA 557
151 GENERAL PHYSICAL HEALTH DETERIORATION 555
152 CELLULITIS 552
153 ASCITES 536
154 DEPRESSED MOOD 526
155 THERAPY CESSATION 526
156 NECK PAIN 524
157 DYSPHONIA 510
158 RENAL IMPAIRMENT 508
159 CARDIAC ARREST 504
160 TINNITUS 503
161 INFUSION SITE INFECTION 499
162 VASCULAR DEVICE INFECTION 499
163 TRANSFUSION 491
164 PRODUCT DOSE OMISSION 484
165 INFUSION SITE HAEMORRHAGE 479
166 THROMBOSIS 477
167 PRESYNCOPE 474
168 INFLUENZA LIKE ILLNESS 473
169 TREATMENT NONCOMPLIANCE 470
170 FEELING HOT 457
171 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 452
172 POLLAKIURIA 448
173 UPPER RESPIRATORY TRACT INFECTION 445
174 CONTUSION 443
175 ARTHRITIS 442
176 DEVICE LEAKAGE 437
177 OVERDOSE 437
178 DRY MOUTH 433
179 ACUTE RESPIRATORY FAILURE 431
180 FLATULENCE 431
181 MUSCULOSKELETAL PAIN 430
182 BALANCE DISORDER 427
183 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 425
184 URTICARIA 418
185 SWELLING FACE 410
186 RENAL DISORDER 405
187 DEVICE OCCLUSION 402
188 VIRAL INFECTION 400
189 CATHETERISATION CARDIAC 395
190 SURGERY 394
191 PULMONARY EMBOLISM 391
192 BLOOD POTASSIUM DECREASED 389
193 CATHETER SITE ERYTHEMA 387
194 LIBIDO DECREASED 384
195 INJECTION SITE ERYTHEMA 376
196 HYPOACUSIS 374
197 ADVERSE EVENT 366
198 ASTHMA 363
199 OXYGEN CONSUMPTION INCREASED 362
200 SINUS DISORDER 362
201 DEVICE MALFUNCTION 361
202 DYSPHAGIA 359
203 SCLERODERMA 358
204 LETHARGY 356
205 OCULAR HYPERAEMIA 351
206 HAEMATOCHEZIA 350
207 INTERSTITIAL LUNG DISEASE 350
208 CATARACT 348
209 SINUS CONGESTION 348
210 BLOOD GLUCOSE INCREASED 344
211 NEUROPATHY PERIPHERAL 344
212 HEAD INJURY 342
213 STRESS 338
214 CATHETER SITE PAIN 334
215 DEAFNESS 334
216 BRAIN NATRIURETIC PEPTIDE INCREASED 331
217 CORONARY ARTERY DISEASE 327
218 PRODUCT USE IN UNAPPROVED INDICATION 326
219 BLOOD CREATININE INCREASED 325
220 INFUSION SITE DISCHARGE 324
221 COMPLICATION ASSOCIATED WITH DEVICE 320
222 HYPERVOLAEMIA 315
223 EYE PAIN 313
224 SEIZURE 312
225 LIBIDO DISORDER 311
226 LUNG TRANSPLANT 310
227 THERAPY CHANGE 306
228 MUSCULOSKELETAL STIFFNESS 301
229 BONE PAIN 300
230 STAPHYLOCOCCAL INFECTION 299
231 PULMONARY ARTERIAL PRESSURE INCREASED 297
232 DEVICE INFUSION ISSUE 293
233 ARRHYTHMIA 291
234 GOUT 291
235 CLOSTRIDIUM DIFFICILE INFECTION 290
236 ADVERSE DRUG REACTION 288
237 LOCALISED INFECTION 287
238 PROSTATE CANCER 286
239 VERTIGO 285
240 WHITE BLOOD CELL COUNT DECREASED 285
241 THROMBOCYTOPENIA 278
242 MALIGNANT MELANOMA IN SITU 277
243 GASTRIC DISORDER 276
244 RECTAL HAEMORRHAGE 274
245 HIP FRACTURE 273
246 ROAD TRAFFIC ACCIDENT 270
247 ALOPECIA 269
248 DRY SKIN 268
249 INTENTIONAL PRODUCT USE ISSUE 267
250 DIZZINESS POSTURAL 266
251 EMOTIONAL DISTRESS 265
252 INFUSION SITE PRURITUS 265
253 HEART RATE DECREASED 263
254 NEOPLASM MALIGNANT 263
255 INTENTIONAL DOSE OMISSION 261
256 RESPIRATORY TRACT CONGESTION 261
257 ASPARTATE AMINOTRANSFERASE INCREASED 259
258 RASH PRURITIC 258
259 EYE SWELLING 255
260 HEAD DISCOMFORT 255
261 PNEUMOTHORAX 255
262 CATHETER SITE INFECTION 254
263 DYSGEUSIA 254
264 RESPIRATORY DISTRESS 254
265 LIVER DISORDER 253
266 AMNESIA 252
267 CATHETER SITE HAEMORRHAGE 252
268 RESPIRATION ABNORMAL 252
269 FEELING COLD 251
270 BURNING SENSATION 250
271 CATHETER SITE PRURITUS 248
272 RESPIRATORY DISORDER 247
273 HEPATIC CIRRHOSIS 245
274 VISUAL ACUITY REDUCED 245
275 HERPES ZOSTER 243
276 DYSURIA 242
277 DISCOMFORT 241
278 EAR INFECTION 241
279 GASTROENTERITIS VIRAL 241
280 SECRETION DISCHARGE 241
281 LIMB DISCOMFORT 239
282 TRANSIENT ISCHAEMIC ATTACK 239
283 CATHETER SITE DISCHARGE 238
284 CENTRAL VENOUS CATHETERISATION 238
285 HYPOKALAEMIA 238
286 MOBILITY DECREASED 238
287 SLEEP APNOEA SYNDROME 236
288 ALANINE AMINOTRANSFERASE INCREASED 235
289 CEREBRAL HAEMORRHAGE 235
290 BLOOD PRESSURE ABNORMAL 234
291 CATHETER MANAGEMENT 232
292 TOXICITY TO VARIOUS AGENTS 232
293 RETCHING 231
294 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 230
295 NERVOUSNESS 229
296 HAEMOGLOBIN INCREASED 228
297 BLINDNESS 227
298 PANCREATITIS 226
299 EXERCISE TOLERANCE DECREASED 224
300 DIALYSIS 223
301 INFUSION SITE REACTION 222
302 BLOOD IRON DECREASED 221
303 RESPIRATORY TRACT INFECTION 220
304 SEPTIC SHOCK 220
305 EXTRA DOSE ADMINISTERED 219
306 HEART RATE IRREGULAR 219
307 LIMB INJURY 219
308 PULMONARY CONGESTION 219
309 DEVICE BREAKAGE 217
310 NEPHROLITHIASIS 216
311 SYSTEMIC LUPUS ERYTHEMATOSUS 215
312 UNDERDOSE 215
313 FREQUENT BOWEL MOVEMENTS 213
314 ATRIAL FLUTTER 211
315 DECREASED ACTIVITY 211
316 SKIN DISCOLOURATION 211
317 DEVICE FAILURE 209
318 BODY HEIGHT DECREASED 207
319 INFUSION SITE INDURATION 207
320 LACRIMATION INCREASED 207
321 PRODUCT SUBSTITUTION ISSUE 207
322 DYSPNOEA AT REST 205
323 DEVICE USE ERROR 203
324 IRON DEFICIENCY ANAEMIA 203
325 INJECTION SITE HAEMORRHAGE 202
326 HYPERSOMNIA 201
327 CONCOMITANT DISEASE AGGRAVATED 199
328 EYE DISORDER 199
329 FAECES SOFT 196
330 BLISTER 195
331 CARDIO-RESPIRATORY ARREST 195
332 FAECES DISCOLOURED 195
333 END STAGE RENAL DISEASE 194
334 DEVICE ALARM ISSUE 192
335 PRODUCT ADMINISTRATION INTERRUPTED 191
336 INTENTIONAL OVERDOSE 190
337 INTESTINAL OBSTRUCTION 190
338 INJECTION SITE SWELLING 189
339 INFUSION SITE IRRITATION 188
340 NEURALGIA 188
341 OBSTRUCTIVE AIRWAYS DISORDER 188
342 INFUSION SITE WARMTH 187
343 INJECTION SITE PRURITUS 187
344 CATHETER PLACEMENT 185
345 PULMONARY FIBROSIS 185
346 RED BLOOD CELL COUNT DECREASED 185
347 ACCIDENTAL OVERDOSE 184
348 SKIN IRRITATION 183
349 HAEMATEMESIS 182
350 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 182
351 DEEP VEIN THROMBOSIS 181
352 LUNG NEOPLASM MALIGNANT 181
353 EAR DISCOMFORT 180
354 DIVERTICULITIS 179
355 HYPONATRAEMIA 177
356 INTERNATIONAL NORMALISED RATIO INCREASED 177
357 INTERNAL HAEMORRHAGE 176
358 ERECTION INCREASED 175
359 CARDIOMEGALY 174
360 CHOLELITHIASIS 174
361 INJECTION SITE DISCHARGE 174
362 NIGHT SWEATS 174
363 ILL-DEFINED DISORDER 173
364 MENTAL STATUS CHANGES 173
365 ANGINA PECTORIS 172
366 JOINT INJURY 171
367 MEDICATION ERROR 171
368 PALLOR 171
369 EYE IRRITATION 168
370 CYANOSIS 167
371 HEPATIC FUNCTION ABNORMAL 167
372 RESTLESS LEGS SYNDROME 167
373 DRY EYE 166
374 SNEEZING 166
375 IRRITABILITY 165
376 RASH ERYTHEMATOUS 165
377 RIB FRACTURE 165
378 PSORIASIS 164
379 SUSPECTED COUNTERFEIT PRODUCT 164
380 DEAFNESS UNILATERAL 163
381 DYSLIPIDAEMIA 162
382 HAEMORRHOIDS 162
383 PRIAPISM 162
384 EAR PAIN 161
385 HAEMATOCRIT DECREASED 160
386 RESPIRATORY SYNCYTIAL VIRUS INFECTION 160
387 NEUTROPENIA 159
388 POOR QUALITY SLEEP 159
389 NO ADVERSE EVENT 158
390 LYMPHADENOPATHY 157
391 INFLAMMATION 156
392 SKIN EXFOLIATION 156
393 WEIGHT FLUCTUATION 156
394 BLOOD GLUCOSE DECREASED 155
395 DRUG ABUSE 155
396 HERNIA 155
397 SENSATION OF FOREIGN BODY 155
398 KIDNEY INFECTION 154
399 LOWER RESPIRATORY TRACT INFECTION 153
400 AGITATION 152
401 DIPLOPIA 152
402 HEPATIC ENZYME INCREASED 152
403 PANCYTOPENIA 152
404 DEVICE MAINTENANCE ISSUE 151
405 LUNG INFECTION 150
406 URINARY RETENTION 150
407 WRONG TECHNIQUE IN DRUG USAGE PROCESS 150
408 SPEECH DISORDER 149
409 BACTERAEMIA 148
410 MUSCULOSKELETAL CHEST PAIN 148
411 TOOTHACHE 148
412 ACUTE MYOCARDIAL INFARCTION 147
413 CYSTITIS 146
414 GAIT INABILITY 146
415 INJECTION SITE INFECTION 146
416 MUSCULOSKELETAL DISCOMFORT 146
417 PNEUMONIA ASPIRATION 146
418 BLOOD ALKALINE PHOSPHATASE INCREASED 145
419 COLITIS 145
420 QUALITY OF LIFE DECREASED 145
421 ANHEDONIA 144
422 EOSINOPHILIA 144
423 OSTEOPOROSIS 144
424 RHEUMATOID ARTHRITIS 144
425 BLOOD COUNT ABNORMAL 143
426 UNRESPONSIVE TO STIMULI 143
427 ERUCTATION 142
428 MICTURITION URGENCY 142
429 BLOOD BILIRUBIN INCREASED 141
430 BLOOD PRESSURE FLUCTUATION 141
431 DISTURBANCE IN ATTENTION 141
432 EYE HAEMORRHAGE 141
433 SUICIDAL IDEATION 141
434 BASAL CELL CARCINOMA 140
435 BRADYCARDIA 140
436 CARDIAC OPERATION 140
437 CARDIAC PACEMAKER INSERTION 140
438 OPTIC ISCHAEMIC NEUROPATHY 139
439 HALLUCINATION 138
440 LIP SWELLING 138
441 PLANTAR FASCIITIS 138
442 WHITE BLOOD CELL COUNT INCREASED 138
443 GALLBLADDER DISORDER 137
444 PANIC ATTACK 137
445 PRODUCT QUALITY ISSUE 136
446 DEVICE RELATED SEPSIS 135
447 GENERALISED OEDEMA 135
448 OBSTRUCTIVE SLEEP APNOEA SYNDROME 135
449 OSTEOARTHRITIS 135
450 HYPOGLYCAEMIA 134
451 PURULENT DISCHARGE 133
452 WOUND 133
453 EXPIRED PRODUCT ADMINISTERED 132
454 FUNGAL INFECTION 132
455 HEPATIC FAILURE 131
456 LOCALISED OEDEMA 131
457 SKIN ULCER 131
458 EXPOSURE DURING PREGNANCY 130
459 RASH MACULAR 130
460 SKIN DISORDER 130
461 URINARY INCONTINENCE 130
462 HAEMATURIA 129
463 MULTIPLE ORGAN DYSFUNCTION SYNDROME 129
464 NOCTURIA 129
465 BACTERIAL INFECTION 128
466 CATHETER SITE SWELLING 128
467 EXOSTOSIS 128
468 BRAIN FOG 127
469 MELAENA 127
470 SUPRAVENTRICULAR TACHYCARDIA 127
471 MYOGLOBIN BLOOD INCREASED 126
472 POST PROCEDURAL COMPLICATION 126
473 COMPLETED SUICIDE 125
474 FRACTIONAL EXHALED NITRIC OXIDE INCREASED 125
475 LABORATORY TEST ABNORMAL 125
476 LEFT VENTRICULAR FAILURE 125
477 THERAPY PARTIAL RESPONDER 125
478 UPPER LIMB FRACTURE 125
479 GASTRITIS 124
480 BLINDNESS UNILATERAL 123
481 INJURY 123
482 SLUGGISHNESS 123
483 INFUSION SITE OEDEMA 121
484 PRODUCT DOSE OMISSION IN ERROR 121
485 THROAT TIGHTNESS 121
486 INFUSION SITE RASH 120
487 MATERNAL EXPOSURE DURING PREGNANCY 119
488 BREAST CANCER 118
489 CATHETER SITE RASH 118
490 PHOTOPHOBIA 118
491 RESTLESSNESS 118
492 SCIATICA 118
493 MOOD ALTERED 117
494 PULMONARY VENO-OCCLUSIVE DISEASE 117
495 RENAL INJURY 117
496 DELIRIUM 116
497 PROSTATIC SPECIFIC ANTIGEN INCREASED 116
498 STENT PLACEMENT 116
499 SUBDURAL HAEMATOMA 116
500 THROMBOSIS IN DEVICE 116
501 ARTHROPATHY 115
502 DISORIENTATION 115
503 DRUG EFFECT DECREASED 115
504 TRANSPLANT EVALUATION 115
505 DEVICE CONNECTION ISSUE 113
506 TASTE DISORDER 113
507 BLOOD SODIUM DECREASED 112
508 CARDIOGENIC SHOCK 112
509 LIVER TRANSPLANT 112
510 DYSSTASIA 111
511 BACK DISORDER 110
512 KNEE ARTHROPLASTY 110
513 NO THERAPEUTIC RESPONSE 110
514 URINE FLOW DECREASED 110
515 DEMENTIA 109
516 INJECTION SITE BRUISING 109
517 MENTAL DISORDER 109
518 PENIS DISORDER 109
519 SPUTUM DISCOLOURED 109
520 UPPER-AIRWAY COUGH SYNDROME 109
521 GASTROENTERITIS 108
522 HOSPICE CARE 108
523 LIVER FUNCTION TEST ABNORMAL 108
524 SINUS HEADACHE 108
525 THERAPEUTIC RESPONSE UNEXPECTED 108
526 BLOOD POTASSIUM INCREASED 107
527 ECZEMA 107
528 EYE PRURITUS 107
529 HIP ARTHROPLASTY 107
530 LIVER FUNCTION TEST INCREASED 107
531 CHROMATURIA 105
532 GLAUCOMA 105
533 MUSCLE TIGHTNESS 105
534 VAGINAL HAEMORRHAGE 105
535 CARDIAC FAILURE ACUTE 104
536 FEEDING DISORDER 104
537 NASAL DRYNESS 104
538 BLOOD URINE PRESENT 103
539 COMA 103
540 HYPERKALAEMIA 103
541 COLD SWEAT 102
542 EJACULATION FAILURE 102
543 HAEMATOMA 102
544 LOWER LIMB FRACTURE 102
545 ORTHOSTATIC HYPOTENSION 102
546 PULMONARY HAEMORRHAGE 102
547 RALES 102
548 RETINAL DETACHMENT 102
549 HYPOPHAGIA 101
550 GINGIVAL BLEEDING 100
551 ACCIDENTAL EXPOSURE TO PRODUCT 99
552 BLOOD PRESSURE SYSTOLIC DECREASED 99
553 GAMMA-GLUTAMYLTRANSFERASE INCREASED 99
554 ISCHAEMIC STROKE 99
555 SPINAL FRACTURE 99
556 STOMATITIS 99
557 INJECTION SITE RASH 98
558 OXYGEN SATURATION ABNORMAL 98
559 TRICUSPID VALVE INCOMPETENCE 98
560 AGEUSIA 97
561 BREATH SOUNDS ABNORMAL 97
562 FEELING JITTERY 97
563 MALIGNANT MELANOMA STAGE I 97
564 NEPHROGENIC ANAEMIA 97
565 SQUAMOUS CELL CARCINOMA 97
566 BRONCHOSPASM 96
567 COLON CANCER 96
568 DYSARTHRIA 96
569 SPONTANEOUS PENILE ERECTION 96
570 URINE OUTPUT DECREASED 96
571 ANKLE FRACTURE 95
572 CARDIAC FLUTTER 95
573 ECONOMIC PROBLEM 95
574 FEMUR FRACTURE 95
575 INFUSION SITE EXTRAVASATION 95
576 PULMONARY MASS 95
577 PULMONARY THROMBOSIS 95
578 RESPIRATORY ARREST 95
579 COGNITIVE DISORDER 94
580 TREATMENT FAILURE 94
581 DEVICE DIFFICULT TO USE 93
582 MOVEMENT DISORDER 93
583 ORAL PAIN 93
584 PARANASAL SINUS DISCOMFORT 93
585 TOOTH DISORDER 93
586 ANORGASMIA 92
587 COVID-19 PNEUMONIA 92
588 HIATUS HERNIA 92
589 HYPOTHYROIDISM 92
590 OROPHARYNGEAL DISCOMFORT 92
591 POLYURIA 92
592 UPPER GASTROINTESTINAL HAEMORRHAGE 92
593 ACNE 91
594 BEDRIDDEN 91
595 BODY TEMPERATURE INCREASED 91
596 HYPERTHYROIDISM 91
597 INFUSION SITE NODULE 91
598 SKIN INFECTION 91
599 VENTRICULAR TACHYCARDIA 91
600 APHASIA 90
601 FLANK PAIN 90
602 MIDDLE INSOMNIA 90
603 PERIPHERAL COLDNESS 90
604 CARDIOVASCULAR DISORDER 89
605 DISEASE COMPLICATION 89
606 GASTRIC HAEMORRHAGE 89
607 INFUSION SITE DISCOMFORT 89
608 OCULAR DISCOMFORT 89
609 CHOLECYSTECTOMY 88
610 DEVICE POWER SOURCE ISSUE 88
611 FOOT FRACTURE 88
612 INTERVERTEBRAL DISC PROTRUSION 88
613 PNEUMONIA BACTERIAL 88
614 TERMINAL STATE 88
615 DEVICE PHYSICAL PROPERTY ISSUE 87
616 BACK INJURY 86
617 BLOOD UREA INCREASED 86
618 DYSKINESIA 86
619 FACE OEDEMA 86
620 PULMONARY ALVEOLAR HAEMORRHAGE 86
621 AGGRESSION 85
622 ANGIOEDEMA 85
623 APHONIA 85
624 C-REACTIVE PROTEIN INCREASED 85
625 CANDIDA INFECTION 85
626 CORONARY ARTERY OCCLUSION 85
627 FULL BLOOD COUNT ABNORMAL 85
628 INFUSION SITE INFLAMMATION 85
629 JOINT STIFFNESS 85
630 LARGE INTESTINE POLYP 85
631 MULTIPLE ALLERGIES 85
632 SARS-COV-2 TEST POSITIVE 85
633 ABSCESS 84
634 INFUSION SITE DISCOLOURATION 84
635 INJECTION SITE IRRITATION 84
636 INTENTIONAL DRUG MISUSE 84
637 ORTHOPNOEA 84
638 THERAPEUTIC RESPONSE INCREASED 84
639 TOOTH INFECTION 84
640 WALKING DISTANCE TEST ABNORMAL 84
641 ANGER 83
642 DISEASE RECURRENCE 83
643 ELECTROLYTE IMBALANCE 83
644 FULL BLOOD COUNT DECREASED 83
645 INCREASED UPPER AIRWAY SECRETION 83
646 RENAL FAILURE ACUTE 83
647 SPINAL OPERATION 83
648 ANAL INCONTINENCE 82
649 CHOKING 82
650 IMPAIRED HEALING 82
651 INJECTION SITE REACTION 82
652 IRRITABLE BOWEL SYNDROME 82
653 MENTAL IMPAIRMENT 82
654 METABOLIC ACIDOSIS 82
655 PULMONARY PAIN 82
656 SKIN LACERATION 82
657 SMALL INTESTINAL OBSTRUCTION 82
658 CONVULSION 81
659 DRUG-INDUCED LIVER INJURY 81
660 GASTRIC ULCER 81
661 LOSS OF LIBIDO 81
662 SUDDEN DEATH 81
663 INSURANCE ISSUE 80
664 INTRAOCULAR PRESSURE INCREASED 80
665 OSTEOMYELITIS 80
666 PNEUMONITIS 80
667 SEXUAL DYSFUNCTION 80
668 CATHETER SITE IRRITATION 79
669 DRUG TITRATION ERROR 79
670 MALIGNANT MELANOMA STAGE IV 79
671 RIGHT VENTRICULAR DYSFUNCTION 79
672 SHOCK 79
673 DRY THROAT 78
674 LARYNGITIS 78
675 PRODUCT LEAKAGE 78
676 CLOSTRIDIUM DIFFICILE COLITIS 77
677 DEVICE WIRELESS COMMUNICATION ISSUE 77
678 JAUNDICE 77
679 LACERATION 77
680 NIGHTMARE 77
681 APPLICATION SITE PRURITUS 76
682 MIDDLE EAR EFFUSION 76
683 NASAL DISCOMFORT 76
684 SPLENOMEGALY 76
685 THYROID DISORDER 76
686 ULCER 76
687 VITREOUS FLOATERS 76
688 CATHETER SITE INFLAMMATION 75
689 CHOKING SENSATION 75
690 DEPRESSED LEVEL OF CONSCIOUSNESS 75
691 DEVICE USE ISSUE 75
692 INFUSION RELATED REACTION 75
693 MALIGNANT MELANOMA STAGE II 75
694 PANCREATITIS ACUTE 75
695 PROCEDURAL PAIN 75
696 THIRST 75
697 ABNORMAL BEHAVIOUR 74
698 EMOTIONAL DISORDER 74
699 LIGAMENT SPRAIN 74
700 MACULAR DEGENERATION 74
701 TACHYPNOEA 74
702 ABNORMAL DREAMS 73
703 ACTINIC KERATOSIS 73
704 EAR CONGESTION 73
705 IMPAIRED GASTRIC EMPTYING 73
706 MOOD SWINGS 73
707 MUSCLE STRAIN 73
708 THERAPEUTIC PRODUCT EFFECT DECREASED 73
709 ULCER HAEMORRHAGE 73
710 BLOOD TEST ABNORMAL 72
711 BONE DENSITY DECREASED 72
712 EYE INFECTION 72
713 HEPATIC ENCEPHALOPATHY 72
714 INFUSION SITE VESICLES 72
715 METASTATIC MALIGNANT MELANOMA 72
716 POST PROCEDURAL HAEMORRHAGE 72
717 PSORIATIC ARTHROPATHY 72
718 SWOLLEN TONGUE 72
719 TOOTH EXTRACTION 72
720 AMMONIA INCREASED 71
721 HEART RATE ABNORMAL 71
722 PRESCRIBED OVERDOSE 71
723 SCAB 71
724 VISUAL FIELD DEFECT 71
725 ATELECTASIS 70
726 BRONCHIECTASIS 70
727 CRYING 70
728 ENCEPHALOPATHY 70
729 HAEMORRHOIDAL HAEMORRHAGE 70
730 HEPATIC STEATOSIS 70
731 INFUSION SITE BRUISING 70
732 INFUSION SITE CELLULITIS 70
733 MEDICAL DEVICE COMPLICATION 70
734 PHARYNGITIS STREPTOCOCCAL 70
735 PROSTATOMEGALY 70
736 RHINOVIRUS INFECTION 70
737 SKIN LESION 70
738 UNINTENTIONAL MEDICAL DEVICE REMOVAL 70
739 VISUAL DISTURBANCE 70
740 BLOOD GLUCOSE ABNORMAL 69
741 EATING DISORDER 69
742 FACIAL PAIN 69
743 OXYGEN THERAPY 69
744 ASPIRATION 68
745 BOWEL MOVEMENT IRREGULARITY 68
746 SYSTEMIC SCLERODERMA 68
747 ANAPHYLACTIC REACTION 67
748 CIRCULATORY COLLAPSE 67
749 DIZZINESS EXERTIONAL 67
750 EMPHYSEMA 67
751 IRON DEFICIENCY 67
752 PERFORMANCE STATUS DECREASED 67
753 PRODUCT USE COMPLAINT 67
754 RASH GENERALISED 67
755 RAYNAUD^S PHENOMENON 67
756 RHINITIS 67
757 ABDOMINAL PAIN LOWER 66
758 CHOLECYSTITIS 66
759 HYPERGLYCAEMIA 66
760 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 66
761 BLADDER CANCER 65
762 CARDIAC ABLATION 65
763 COLITIS ULCERATIVE 65
764 CYANOPSIA 65
765 DRUG WITHDRAWAL SYNDROME 65
766 GLOMERULAR FILTRATION RATE DECREASED 65
767 HYPERCHOLESTEROLAEMIA 65
768 MUSCLE ATROPHY 65
769 RENAL PAIN 65
770 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 65
771 BLINDNESS TRANSIENT 64
772 CEREBRAL INFARCTION 64
773 DRUG DEPENDENCE 64
774 DRUG EFFECT INCOMPLETE 64
775 EJACULATION DISORDER 64
776 FIBROMYALGIA 64
777 LOCAL SWELLING 64
778 OSTEOPENIA 64
779 PLASMA CELL MYELOMA 64
780 ROTATOR CUFF SYNDROME 64
781 TOOTH ABSCESS 64
782 WRIST FRACTURE 64
783 ACUTE RESPIRATORY DISTRESS SYNDROME 63
784 INITIAL INSOMNIA 63
785 MALNUTRITION 63
786 PARKINSON^S DISEASE 63
787 PHARYNGITIS 63
788 ATRIAL SEPTAL DEFECT 62
789 CONJUNCTIVITIS 62
790 DRUG TOLERANCE DECREASED 62
791 EYELID OEDEMA 62
792 GYNAECOMASTIA 62
793 INCORRECT DRUG ADMINISTRATION RATE 62
794 MALIGNANT NEOPLASM PROGRESSION 62
795 PARANASAL SINUS HYPERSECRETION 62
796 PRODUCT ADMINISTRATION ERROR 62
797 PULMONARY HYPERTENSIVE CRISIS 62
798 SUBARACHNOID HAEMORRHAGE 62
799 UPPER RESPIRATORY TRACT CONGESTION 62
800 VENTRICULAR FIBRILLATION 62
801 ACCIDENT 61
802 AUTOIMMUNE DISORDER 61
803 CONTRAINDICATED PRODUCT ADMINISTERED 61
804 HAEMODYNAMIC INSTABILITY 61
805 SKIN BURNING SENSATION 61
806 TYPE 2 DIABETES MELLITUS 61
807 ABASIA 60
808 BLOOD PRESSURE DIASTOLIC DECREASED 60
809 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 60
810 ECHOCARDIOGRAM ABNORMAL 60
811 GROIN PAIN 60
812 HYPERLIPIDAEMIA 60
813 HYPERPARATHYROIDISM SECONDARY 60
814 INFUSION SITE ABSCESS 60
815 INJECTION SITE INDURATION 60
816 KNEE OPERATION 60
817 MALIGNANT MELANOMA STAGE III 60
818 PELVIC FRACTURE 60
819 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 60
820 BLADDER DISORDER 59
821 BLOOD MAGNESIUM DECREASED 59
822 HAEMORRHAGE INTRACRANIAL 59
823 HEMIPARESIS 59
824 INCREASED APPETITE 59
825 LEUKOPENIA 59
826 MULTIPLE SCLEROSIS RELAPSE 59
827 PREMATURE BABY 59
828 PRURITUS GENERALISED 59
829 RIGHT VENTRICULAR DILATATION 59
830 SCAR 59
831 DRUG ADMINISTRATION ERROR 58
832 HEPATOMEGALY 58
833 MOUTH HAEMORRHAGE 58
834 NEPHROPATHY 58
835 ORAL CANDIDIASIS 58
836 PARACENTESIS 58
837 TUBULOINTERSTITIAL NEPHRITIS 58
838 DIVERTICULUM 57
839 FEAR 57
840 OESOPHAGITIS 57
841 PENILE PAIN 57
842 PRODUCT DISTRIBUTION ISSUE 57
843 PROSTATITIS 57
844 SKIN CANCER 57
845 CATHETER SITE VESICLES 56
846 GASTROINTESTINAL INFECTION 56
847 GLYCOSYLATED HAEMOGLOBIN INCREASED 56
848 HYSTERECTOMY 56
849 ILEUS 56
850 MENORRHAGIA 56
851 MUSCLE TWITCHING 56
852 NOCTURNAL DYSPNOEA 56
853 TENDONITIS 56
854 TESTICULAR PAIN 56
855 VIRAL UPPER RESPIRATORY TRACT INFECTION 56
856 CARDIAC FAILURE CHRONIC 55
857 CROHN^S DISEASE 55
858 IDIOPATHIC PULMONARY FIBROSIS 55
859 MECHANICAL VENTILATION 55
860 PREGNANCY 55
861 EPILEPSY 54
862 INJECTION SITE MASS 54
863 INTESTINAL HAEMORRHAGE 54
864 MITRAL VALVE INCOMPETENCE 54
865 PNEUMONIA VIRAL 54
866 SENSORY DISTURBANCE 54
867 SUDDEN HEARING LOSS 54
868 APATHY 53
869 APPETITE DISORDER 53
870 CARPAL TUNNEL SYNDROME 53
871 COR PULMONALE 53
872 DRUG PRESCRIBING ERROR 53
873 EXTRASYSTOLES 53
874 GASTROINTESTINAL PAIN 53
875 HICCUPS 53
876 LEUKOCYTOSIS 53
877 PHOTOPSIA 53
878 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 53
879 SPINAL COMPRESSION FRACTURE 53
880 THERAPEUTIC RESPONSE DELAYED 53
881 DRUG ERUPTION 52
882 FOOD POISONING 52
883 INFUSION SITE MASS 52
884 PHOTOSENSITIVITY REACTION 52
885 POLYP 52
886 PORTAL HYPERTENSION 52
887 PRODUCT AVAILABILITY ISSUE 52
888 RASH PAPULAR 52
889 AORTIC STENOSIS 51
890 APPENDICITIS 51
891 BLOOD LOSS ANAEMIA 51
892 BLOOD PRESSURE SYSTOLIC INCREASED 51
893 GASTROINTESTINAL MOTILITY DISORDER 51
894 GLOSSODYNIA 51
895 PULMONARY ARTERIAL PRESSURE ABNORMAL 51
896 SKIN ABRASION 51
897 BRAIN INJURY 50
898 CATARACT OPERATION 50
899 COAGULOPATHY 50
900 CYST 50
901 FOETAL EXPOSURE DURING PREGNANCY 50
902 HYPOAESTHESIA ORAL 50
903 INCORRECT DOSE ADMINISTERED BY DEVICE 50
904 LYMPHOMA 50
905 TRISMUS 50
906 TROPONIN INCREASED 50
907 VASCULAR DEVICE OCCLUSION 50
908 AORTIC ANEURYSM 49
909 ARTERIOSCLEROSIS 49
910 BLOOD CREATINE PHOSPHOKINASE INCREASED 49
911 BLOOD CULTURE POSITIVE 49
912 CARDIAC VALVE DISEASE 49
913 CONCUSSION 49
914 DERMATITIS ATOPIC 49
915 ELECTROCARDIOGRAM QT PROLONGED 49
916 MASS 49
917 NERVE COMPRESSION 49
918 PROCEDURAL COMPLICATION 49
919 STAPHYLOCOCCAL BACTERAEMIA 49
920 ATRIAL TACHYCARDIA 48
921 BREAST PAIN 48
922 CARDIOMYOPATHY 48
923 FRACTURE 48
924 MULTIPLE SCLEROSIS 48
925 OBESITY 48
926 PARANOIA 48
927 PRODUCT PHYSICAL ISSUE 48
928 RHABDOMYOLYSIS 48
929 TELANGIECTASIA 48
930 TEMPERATURE INTOLERANCE 48
931 UROSEPSIS 48
932 WITHDRAWAL SYNDROME 48
933 ABNORMAL SENSATION IN EYE 47
934 APPLICATION SITE ERYTHEMA 47
935 INCONTINENCE 47
936 INTERVERTEBRAL DISC DEGENERATION 47
937 PANCREATIC CARCINOMA 47
938 POST PROCEDURAL INFECTION 47
939 RENAL CANCER 47
940 SUICIDE ATTEMPT 47
941 SWELLING OF EYELID 47
942 VASODILATATION 47
943 CATHETER SITE RELATED REACTION 46
944 ENDOCARDITIS 46
945 GASTRIC INFECTION 46
946 HEPATIC CANCER 46
947 HYPERAESTHESIA 46
948 INJECTION SITE WARMTH 46
949 METASTASES TO LIVER 46
950 MYOCARDIAL ISCHAEMIA 46
951 NODULE 46
952 NON-CARDIAC CHEST PAIN 46
953 APPLICATION SITE PAIN 45
954 BLOOD DISORDER 45
955 COUNTERFEIT DRUG ADMINISTERED 45
956 HAEMATOSPERMIA 45
957 LIVER INJURY 45
958 LYMPHOEDEMA 45
959 PERICARDITIS 45
960 SKIN FISSURES 45
961 SKIN HAEMORRHAGE 45
962 VITAMIN D DECREASED 45
963 ARTERIAL OCCLUSIVE DISEASE 44
964 BLOOD GLUCOSE FLUCTUATION 44
965 CARBON DIOXIDE INCREASED 44
966 CARDIAC FAILURE HIGH OUTPUT 44
967 CARDIOVERSION 44
968 CATHETER SITE EXTRAVASATION 44
969 CHOLESTASIS 44
970 CONGENITAL HIATUS HERNIA 44
971 CORONAVIRUS INFECTION 44
972 DENTAL CARIES 44
973 DEVICE ADHESION ISSUE 44
974 EJACULATION DELAYED 44
975 EMERGENCY CARE 44
976 GENERALISED TONIC-CLONIC SEIZURE 44
977 HAEMORRHAGIC STROKE 44
978 HYPOKINESIA 44
979 TRANSAMINASES INCREASED 44
980 WRONG DOSE 44
981 ACUTE PULMONARY OEDEMA 43
982 BLOOD CALCIUM DECREASED 43
983 DECUBITUS ULCER 43
984 DIABETIC NEUROPATHY 43
985 GINGIVAL PAIN 43
986 HYPERCALCAEMIA 43
987 HYPERCAPNIA 43
988 NERVE INJURY 43
989 PARAESTHESIA ORAL 43
990 PERIORBITAL SWELLING 43
991 RETINAL HAEMORRHAGE 43
992 SARCOIDOSIS 43
993 SCRATCH 43
994 THINKING ABNORMAL 43
995 VENTRICULAR EXTRASYSTOLES 43
996 ACTIVITIES OF DAILY LIVING IMPAIRED 42
997 ANOSMIA 42
998 CHEMOTHERAPY 42
999 EXPOSURE VIA SKIN CONTACT 42